Jan Case has more than 25 years of operating and consulting experience in the life sciences industry. As President of Cellicon Valley Consulting, she has partnered with Biotech start-ups, particularly in the cell and gene therapy space, to grow and scale their businesses through fundraising, business development, and R&D portfolio optimization.

Previously, Ms. Case was Head of R&D Operations and Program Management at Spark Therapeutics, where she was a key member of the pioneering team responsible for the approval of Luxturna, the first FDA approved gene therapy for a genetic disease. Previously, she spent 10+ years at Shire (now Takeda) in roles with increasing responsibility in program and portfolio management and corporate development. She joined Shire after 5 years as a management consultant and a decade working in product development in Europe.

Ms. Case earned a BSc in Biochemistry and Physiology from Southampton University and an MSc in Medical Informatics from City University/UMDS in London. She has also completed an Executive CPD program at Wharton.